PerkinElmer debuts dried blood spot-based COVID-19 serology test

2020 06 17 20 35 0417 Covid 19 Antibody 400

PerkinElmer has introduced a dry blood spot-based serology test for SARS-CoV-2 immunoglobulin G (IgG) antibodies using its genetic screening processor (GSP)/dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA) platforms.

Up to 5,000 samples of the fully automated kit can be processed per day, according to the company. PerkinElmer said that the finger-prick sample collection devices enable both decentralized sample collection and high-throughput testing.

In Europe, the kit is being marketed as a CE-IVD test. The firm plans to apply for an emergency use authorization with the U.S. Food and Drug Administration.

Page 1 of 13
Next Page